Literature DB >> 10490795

Free fatty acids and insulin levels--relationship to leptin levels and body composition in various patient groups from South Africa.

M T der Merwe1, V R Panz, N J Crowther, G P Schlaphoff, I P Gray, P Froguel, B I Joffe, P N Lönnroth.   

Abstract

OBJECTIVE: To investigate the relationship between leptin concentrations, various metabolic indices and body composition in six different groups. DESIGN AND MEASUREMENTS: Anthropometric measurements, fasting plasma glucose, serum insulin, C-peptide, FFA and leptin levels were performed. In the obese and diabetic subjects, body composition was analysed with bio-impedance equipment and as a 5 level CT scan.
SUBJECTS: Five lipoatrophic diabetes mellitus (LDM) patients, five normal subjects (N), nine white and nine black obese women (WW, BW), and nine white and nine black diabetic women (DWW, DBW) were investigated after an overnight fast.
RESULTS: In both ethnic groups there was a positive correlation between leptin and BMI (black group: r=0.8; P<0.0001, white group: r=0.7, P<0.002) and leptin and SC fat mass (black group: r=0.6; P<0.005, white group: r=0.6; P<0.004).
CONCLUSIONS: Across the groups, there were positive linear correlations between leptin concentrations, BMI, SC fat mass and FFA levels. Leptin and FFA concentrations are higher and insulin levels lower in both groups of black women compared to the two groups of white women, despite a similar BMI and body fat mass. In the DBW the large increase in visceral fat mass may be indicative of a more complex relationship between compensatory insulin resistance, elevated FFA levels and leptin secretion.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10490795     DOI: 10.1038/sj.ijo.0800969

Source DB:  PubMed          Journal:  Int J Obes Relat Metab Disord


  7 in total

1.  Greater adipose tissue infiltration in skeletal muscle among older men of African ancestry.

Authors:  Iva Miljkovic; Jane A Cauley; Moira A Petit; Kristine E Ensrud; Elsa Strotmeyer; Yahtyng Sheu; Christopher L Gordon; Bret H Goodpaster; Clareann H Bunker; Alan L Patrick; Victor W Wheeler; Lewis H Kuller; Kimberly A Faulkner; Joseph M Zmuda
Journal:  J Clin Endocrinol Metab       Date:  2009-05-19       Impact factor: 5.958

2.  Gluconeogenesis and risk for fasting hyperglycemia in Black and White women.

Authors:  Stephanie T Chung; Amber B Courville; Anthony U Onuzuruike; Mirella Galvan-De La Cruz; Lilian S Mabundo; Christopher W DuBose; Kannan Kasturi; Hongyi Cai; Ahmed M Gharib; Peter J Walter; H Martin Garraffo; Shaji Chacko; Morey W Haymond; Anne E Sumner
Journal:  JCI Insight       Date:  2018-09-20

3.  Review: Metabolic Syndrome in Black South African Women.

Authors:  Philippe Jean-Luc Gradidge; Nigel J Crowther
Journal:  Ethn Dis       Date:  2017-04-20       Impact factor: 1.847

4.  Intralipid/heparin infusion suppresses serum leptin in humans.

Authors:  P Garcia-Lorda; Wendy Nash; Ansley Roche; F-X Pi-Sunyer; B Laferrere
Journal:  Eur J Endocrinol       Date:  2003-06       Impact factor: 6.664

5.  Adipose tissue infiltration in skeletal muscle: age patterns and association with diabetes among men of African ancestry.

Authors:  Iva Miljkovic-Gacic; Christopher L Gordon; Bret H Goodpaster; Clareann H Bunker; Alan L Patrick; Lewis H Kuller; Victor W Wheeler; Rhobert W Evans; Joseph M Zmuda
Journal:  Am J Clin Nutr       Date:  2008-06       Impact factor: 7.045

6.  Sex and genetic effects on upper and lower body fat and associations with diabetes in multigenerational families of African heritage.

Authors:  Iva Miljkovic-Gacic; Xiaojing Wang; Candace M Kammerer; Clareann H Bunker; Alan L Patrick; Victor W Wheeler; Lewis H Kuller; Rhobert W Evans; Joseph M Zmuda
Journal:  Metabolism       Date:  2008-06       Impact factor: 8.694

7.  Serum leptin concentrations are not related to dietary patterns but are related to sex, age, body mass index, serum triacylglycerol, serum insulin, and plasma glucose in the US population.

Authors:  Vijay Ganji; Mohammad R Kafai; Erin McCarthy
Journal:  Nutr Metab (Lond)       Date:  2009-01-14       Impact factor: 4.169

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.